UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

The New England journal of medicine, 2017-06, Vol.376 (25), p.2448-2458

2017

Link zum Volltext

Verfügbarkeit prüfen

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

The New England journal of medicine, 2017-10, Vol.377 (17), p.1613-1629

2017

Link zum Volltext

Verfügbarkeit prüfen

Mild asthma: Lessons learned and remaining questions

Respiratory medicine, 2023-09, Vol.216, p.107326-107326, Article 107326

2023

Link zum Volltext

Verfügbarkeit prüfen

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

Science translational medicine, 2020-11, Vol.12 (570)

2020

Link zum Volltext

Verfügbarkeit prüfen

Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis

Allergy (Copenhagen), 2022-01, Vol.77 (1), p.150-161

2022

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil extracellular traps and thrombosis in COVID-19

Journal of thrombosis and thrombolysis, 2021-02, Vol.51 (2), p.446-453

2021

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil calprotectin identifies severe pulmonary disease in COVID‐19

Journal of leukocyte biology, 2021-01, Vol.109 (1), p.67-72

2021

Link zum Volltext

Verfügbarkeit prüfen

Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions

Annals of allergy, asthma, & immunology, 2022-08, Vol.129 (2), p.169-180

2022

Link zum Volltext

Verfügbarkeit prüfen

Revisiting Mild Asthma: Current Knowledge and Future Needs

Chest, 2022-01, Vol.161 (1), p.26-39

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Clinical therapeutics, 2016-09, Vol.38 (9), p.2058-2070.e1

2016

Link zum Volltext

Verfügbarkeit prüfen

Does obesity produce a distinct asthma phenotype?

Journal of applied physiology (1985), 2010-03, Vol.108 (3), p.729-734

2010

Link zum Volltext

Verfügbarkeit prüfen

Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline

Respiratory medicine, 2022-10, Vol.202, p.106938-106938, Article 106938

2022

Link zum Volltext

Verfügbarkeit prüfen

Are We Ready for Asthma Remission as a Clinical Outcome?

Chest, 2023-10, Vol.164 (4), p.831-834

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of mepolizumab in patients with high-burden severe asthma within a managed care population

The Journal of asthma, 2023-04, Vol.60 (4), p.811-823

2023

Link zum Volltext

Verfügbarkeit prüfen

Obesity, metabolic dysregulation and oxidative stress in asthma

Biochimica et biophysica acta, 2011-11, Vol.1810 (11), p.1120-1126

2011

Link zum Volltext

Verfügbarkeit prüfen

Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2022-02, Vol.10 (2), p.422-432

2022

Link zum Volltext

Verfügbarkeit prüfen

Type 2 Biomarkers in Asthma: Yet Another Reflection of Heterogeneity

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2021-03, Vol.9 (3), p.1276-1277

2021

Link zum Volltext

Verfügbarkeit prüfen

Blood eosinophil count group shifts and kinetics in severe eosinophilic asthma

Annals of allergy, asthma, & immunology, 2020-08, Vol.125 (2), p.171-176

2020

Link zum Volltext

Verfügbarkeit prüfen

HuR-Targeted Inhibition Impairs Th2 Proinflammatory Responses in Asthmatic CD4 + T Cells

The Journal of immunology (1950), 2022-01, Vol.208 (1), p.38-48

2022

Link zum Volltext

Verfügbarkeit prüfen

Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment

Journal of allergy and clinical immunology, 2017-07, Vol.140 (1), p.63-75

2017

Link zum Volltext

Verfügbarkeit prüfen

Medication Regimens for Managing Stable Asthma

Respiratory care, 2018-06, Vol.63 (6), p.759-772

2018

Link zum Volltext

Verfügbarkeit prüfen

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

The lancet respiratory medicine, 2021-03, Vol.9 (3), p.260-274

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 vaccines: a triumph of science and collaboration

JCI insight, 2021-05, Vol.6 (9)

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictors of response to tiotropium versus salmeterol in asthmatic adults

Journal of allergy and clinical immunology, 2013-11, Vol.132 (5), p.1068-1074.e1

2013

Link zum Volltext

Verfügbarkeit prüfen

Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma

Annals of allergy, asthma, & immunology, 2019-05, Vol.122 (5), p.478-485

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(186)
Mit Volltextzugriff
(183)

Publikationsform

Sprache

Englisch
(197)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

Mild asthma: Lessons learned and remaining questions

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis

Neutrophil extracellular traps and thrombosis in COVID-19

Neutrophil calprotectin identifies severe pulmonary disease in COVID‐19

Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions

Revisiting Mild Asthma: Current Knowledge and Future Needs

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Does obesity produce a distinct asthma phenotype?

Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline

Are We Ready for Asthma Remission as a Clinical Outcome?

Impact of mepolizumab in patients with high-burden severe asthma within a managed care population

Obesity, metabolic dysregulation and oxidative stress in asthma

Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion

Type 2 Biomarkers in Asthma: Yet Another Reflection of Heterogeneity

Blood eosinophil count group shifts and kinetics in severe eosinophilic asthma

HuR-Targeted Inhibition Impairs Th2 Proinflammatory Responses in Asthmatic CD4 + T Cells

Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment

Medication Regimens for Managing Stable Asthma

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

SARS-CoV-2 vaccines: a triumph of science and collaboration

Predictors of response to tiotropium versus salmeterol in asthmatic adults

Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma

Suchergebnisse filtern